格林在编程细胞死亡中的新兴相关性及其在疾病中的应用
Xue Zhang1, Zihan Zeng1, Yaning Liu1
1Queen Mary College, Nanchang University, Xuefu Road, Nanchang 330001, China.
International journal of molecular sciences
|December 23, 2023
概括
ghrelin 是一种调节饥饿感的激素,它也会影响细胞死亡 (PCD) 路径,如亡和热亡. 这篇评论探讨了格林林的作用.
科学领域:
- 内分泌学和分子生物学
- 细胞生物学和病理生理学
背景情况:
- 格林是一种28氨基酸激素,最初因其在生长激素调节和食欲控制中的作用而被确定.
- 新兴研究揭示了格林在整个生理系统的更广泛的影响,以及它在各种疾病中的治疗潜力.
- 格雷林表现出抗炎,抗氧化和抗质性质,这表明它在调节编程细胞死亡 (PCD) 信号传递方面发挥了作用.
研究的目的:
- 阐明格林和不同形式的编程细胞死亡 (PCD) 之间的复杂关系.
- 审查当前对格林在亡,亡,自和亡中的机制的理解.
- 根据其对PCD的多方面的影响,探索格林的潜在临床应用.
主要方法:
- 关于研究格林在编程细胞死亡中的作用的综合文献综述.
- 分析参与林介导的亡,亡,自和亡的信号通路.
- 综合发现,以确定治疗目标和临床应用.
主要成果:
- 格林在调节多种PCD途径方面表现出显著的参与,包括亡,亡,自和热.
- 有证据表明,格林通过其抗炎,抗氧化和抗形作用对细胞损伤有保护作用.
- 格林对不同类型的PCD影响的精确分子机制需要进一步研究.
结论:
- 格林是一种类激素,在调节细胞死亡方面起着至关重要的作用.
- 了解格林与PCD通路的复杂相互作用,为新的治疗策略开辟了道路.
- 需要进一步的研究,以充分利用格林在治疗与异常细胞死亡相关的疾病的潜力.
更多相关视频
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
8.6K
12:44Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
Published on: October 11, 2012
23.4K
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Phagocytosis of Apoptotic Cells
3.8K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.8K
G Protein-coupled Receptors
12.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.1K
Glucagon-like Receptor Agonists
327
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
327
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
